Stay updated on Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's version tag was updated from v3.6.3 to v3.6.4, signaling a minor platform update with no changes to the study details.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a small update to the page version.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating an updated page version.SummaryDifference0.1%

- Check51 days agoChange DetectedRecruitment status now indicates no participants are being sought, and new guidance sections were added to help users read the study record and join the study. The revision tag was updated to v3.6.0 and the Intervention/Treatment heading formatting was adjusted.SummaryDifference0.6%

- Check58 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor update to the page version.SummaryDifference0.1%

- Check79 days agoChange Detected- The page now displays Revision: v3.5.4, replacing v3.5.3. This indicates a version update to the page's revision metadata.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.